ARMOTRAZ

About

Anastrozole is a potent and selective non-steroidal aromatase inhibitor indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer and for the first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown metastatic breast cancer. It works by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogens in peripheral tissues.

By significantly reducing circulating estrogen levels, anastrozole deprives estrogen-dependent breast cancer cells of the growth stimulus, thereby slowing or stopping tumor progression. This mechanism makes it particularly effective in postmenopausal women where estrogen production primarily occurs extragonadally. It is a crucial component of endocrine therapy for breast cancer management.

Uses

• Adjuvant treatment of early breast cancer.
• First-line treatment of metastatic breast cancer.
• Treatment of advanced breast cancer after tamoxifen.
• Hormone receptor-positive breast cancer in postmenopausal women.

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your oncologist. Do not stop treatment without consulting your doctor.

Benefits

• Effective in hormone receptor-positive breast cancer.
• Significantly reduces estrogen levels.
• Oral, once-daily administration.
• Can reduce recurrence risk in early breast cancer.
• Improves progression-free survival in metastatic disease.
• Generally well-tolerated compared to chemotherapy.

Side Effects

• Hot flashes
• Joint pain (arthralgia)
• Nausea
• Fatigue
• Headache
• Bone pain
• Osteoporosis
• Vaginal dryness
• Hair thinning
• Peripheral edema
• Hypertension
• Rash

Safety Measures

• Alcohol - Moderate alcohol consumption is generally not contraindicated, but excessive intake should be avoided due to potential liver strain.
• Pregnancy - Anastrozole is contraindicated in premenopausal women and during pregnancy due to potential harm to the fetus.
• Breastfeeding - Anastrozole is not indicated for use in premenopausal women and should not be used during breastfeeding due to potential harm to the infant.
• Liver - Use with caution in patients with moderate to severe liver impairment. Close monitoring of liver function is recommended.
• Kidney - No dosage adjustment is typically required for patients with mild to moderate renal impairment. Use with caution in severe impairment.
• Lung - No specific precautions for lung conditions are typically noted for anastrozole.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.